Introduction

Medicilon was founded in 2004 with the explicit purpose of providing fully integrated pharmaceutical services to the global pharmaceutical community. The company抯 integrated services across biology, chemistry and preclinical services are specially designed to help clients develop their research and discovery programs from the initial idea stage to the IND filing phase.

Our headquarters is located in Zhangjiang High-Tech Park in Shanghai, China, with an additional facility in Chuansha Economic Park, Shanghai, China. We occupy over 200,000 SF lab space and have over 300 employees cross biology, chemistry and preclinical research. Over 50% employees have MS and PhD degrees, over 10% have foreign education and/or working experiences.

Vision: Become the top CRO in China to provide high quality preclinical drug discovery and development services to global pharmaceutical and biotechnology companies.

Mission: Quality Research. Global Reach.

Medicilon has been recognized as one of the top drug discovery contract research organizations (CRO) in China and is managed by a team of scientists with many years of experience in US-based pharmaceutical and biotechnology companies. As our areas of expertise and service capabilities continue to expand, major pharmaceutical and biotechnology companies from across 4 continents have taken advantage of our integrated drug discovery and development services.

Lastest Products

Molecular Biology